Rafael Fabián Chávez Naranjo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rafael Fabián Chávez Naranjo has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- David Israel Meza López
Medicine Department of the Institute of Health Sciences of the Autonomous University of the State of Hidalgo (UAEH), Circuito ex-Hacienda La Concepción s/n Carretera Pachuca-Actopan San Agustín Tlaxiaca, Hidalgo, C.P, 42160, México
2 shared publications - Iris Cristina López Santillán
Universidad Autónoma del Estado de Hidalgo
2 shared publications - Selene Michele León León
Medicine Department of the Institute of Health Sciences of the Autonomous University of the State of Hidalgo (UAEH), Circuito ex-Hacienda La Concepción s/n Carretera Pachuca-Actopan San Agustín Tlaxiaca, Hidalgo, C.P, 42160, México
2 shared publications - Ana Hilda Figueroa Gutiérrez
Universidad Autónoma del Estado de Hidalgo
1 shared publication Astrid Espinosa-Sánchez
Medicine Department of the Institute of Health Sciences of the Autonomous University of the State of Hidalgo (UAEH), Circuito ex-Hacienda La Concepción s/n Carretera Pachuca-Actopan San Agustín Tlaxiaca, Hidalgo, C.P, 42160, México
1 shared publication- José Antonio Estefes-Duarte
Universidad Autónoma del Estado de Hidalgo
1 shared publication
Latest Publications
- 8 October 2026
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 22
Therapeutic Management of Drug-susceptible Tuberculosis Among Adults in North American Countries
Introduction/Objective: Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. It is transmitted through the air and can affect various human tissues, particularly the lungs. TB remains a major global health challenge and a significant public health problem because of its airborne transmission and socioeconomic impact on affected individuals. The objective of this study is to evaluate the implementation of the World Health Organization (WHO) guidelines for the management of drug-susceptible tuberculosis among adults in North American countries. Methods: This study analyzes standardized treatment regimens in Mexico, the United States, and Canada. It assesses the clinical application of antituberculosis drugs, including isoniazid, pyrazinamide, ethambutol, rifampicin, rifapentine, rifabutin, moxifloxacin, and levofloxacin, within their respective national healthcare systems. This research analyzes standardized treatment schemes in Mexico, the United States, and Canada. Results: While treatment protocols in Canada, Mexico, and the United States are consistent with the recommendations of WHO guidelines, specific treatment regimens are tailored to the demographic and clinical needs of each population. Thus, these adaptations may influence healthcare coverage and the overall clinical effectiveness of the interventions. Discussion: Differences in how countries implement their TB control strategies may be associated with several epidemiological patterns. The significance of these findings lies in the possibility that variations in resource availability and differences in the adaptation of clinical guidelines may contribute to the observed epidemiological factors of TB across the region. Conclusion: North American countries have adapted their TB treatment regimens over time in accordance with international standards. However, differences in implementation and resource availability may be associated with variations in TB incidence and mortality rates. Strengthening universal access to TB prevention, diagnosis, and treatment remains essential to reduce catastrophic health expenditures and control the TB epidemic.
- 8 October 2026
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 22
Therapeutic Management of Drug-susceptible Tuberculosis Among Adults in North American Countries
Introduction/Objective: Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. It is transmitted through the air and can affect various human tissues, particularly the lungs. TB remains a major global health challenge and a significant public health problem because of its airborne transmission and socioeconomic impact on affected individuals. The objective of this study is to evaluate the implementation of the World Health Organization (WHO) guidelines for the management of drug-susceptible tuberculosis among adults in North American countries. Methods: This study analyzes standardized treatment regimens in Mexico, the United States, and Canada. It assesses the clinical application of antituberculosis drugs, including isoniazid, pyrazinamide, ethambutol, rifampicin, rifapentine, rifabutin, moxifloxacin, and levofloxacin, within their respective national healthcare systems. This research analyzes standardized treatment schemes in Mexico, the United States, and Canada. Results: While treatment protocols in Canada, Mexico, and the United States are consistent with the recommendations of WHO guidelines, specific treatment regimens are tailored to the demographic and clinical needs of each population. Thus, these adaptations may influence healthcare coverage and the overall clinical effectiveness of the interventions. Discussion: Differences in how countries implement their TB control strategies may be associated with several epidemiological patterns. The significance of these findings lies in the possibility that variations in resource availability and differences in the adaptation of clinical guidelines may contribute to the observed epidemiological factors of TB across the region. Conclusion: North American countries have adapted their TB treatment regimens over time in accordance with international standards. However, differences in implementation and resource availability may be associated with variations in TB incidence and mortality rates. Strengthening universal access to TB prevention, diagnosis, and treatment remains essential to reduce catastrophic health expenditures and control the TB epidemic.
- Open Access
- 5 June 2022
- Published by Universidad Autonoma del Estado de Hidalgo in Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo
- Vol. 10 (20) , 98-104
Las TIC como herramientas para la educación médica en la UAEH en tiempos de COVID 19, una perspectiva dual.
A partir del surgimiento de la pandemia por COVID-19, la población global modificó sus entornos educativos a fin de respetar el distanciamiento social recomendado. La educación médica no ha sido la excepción, migrando hacia entornos virtuales de aprendizaje, mediante el uso de diversas plataformas y herramientas que han permitido la interacción a distancia entre docentes y estudiantes, dando continuidad a la enseñanza. La emergencia sanitaria actual ha provocado el aprovechamiento de las Tecnologías de la Información y la Comunicación (TIC) para la continuación del proceso; sin embargo, la comunidad no estaba suficientemente preparada para enfrentar tal situación. Para conocer mejor las condiciones en que se han llevado a cabo estas actividades, se elaboró y aplicó una encuesta a la población académica y estudiantil de la Licenciatura de Médico Cirujano de la Universidad Autónoma del Estado de Hidalgo (UAEH), con la finalidad de identificar el uso de las TIC antes y durante la contingencia por COVID-19, desde una perspectiva dual de alumnos y profesores. Se encontró una migración a escenarios 100% virtuales, mediante un cambio radical hacia la adopción de tecnologías como aplicaciones de comunicación, plataformas de aula virtual y aplicación de exámenes, por alumnos y docentes, durante la contingencia.
- 5 June 2022
- Published by Universidad Autonoma del Estado de Hidalgo in Educación y Salud Boletín Científico Instituto de Ciencias de la Salud Universidad Autónoma del Estado de Hidalgo
- Vol. 10 (20) , 98-104
Open AccessLas TIC como herramientas para la educación médica en la UAEH en tiempos de COVID 19, una perspectiva dual.
A partir del surgimiento de la pandemia por COVID-19, la población global modificó sus entornos educativos a fin de respetar el distanciamiento social recomendado. La educación médica no ha sido la excepción, migrando hacia entornos virtuales de aprendizaje, mediante el uso de diversas plataformas y herramientas que han permitido la interacción a distancia entre docentes y estudiantes, dando continuidad a la enseñanza. La emergencia sanitaria actual ha provocado el aprovechamiento de las Tecnologías de la Información y la Comunicación (TIC) para la continuación del proceso; sin embargo, la comunidad no estaba suficientemente preparada para enfrentar tal situación. Para conocer mejor las condiciones en que se han llevado a cabo estas actividades, se elaboró y aplicó una encuesta a la población académica y estudiantil de la Licenciatura de Médico Cirujano de la Universidad Autónoma del Estado de Hidalgo (UAEH), con la finalidad de identificar el uso de las TIC antes y durante la contingencia por COVID-19, desde una perspectiva dual de alumnos y profesores. Se encontró una migración a escenarios 100% virtuales, mediante un cambio radical hacia la adopción de tecnologías como aplicaciones de comunicación, plataformas de aula virtual y aplicación de exámenes, por alumnos y docentes, durante la contingencia.